Chapter
Chapter 1. Experimental Autoimmune Encephalomyelitis
in the Mouse
I. Introduction: Murine Experimental Autoimmune Encephalomyelitis as a Model for T-CelI-Mediated Demyelinating Disease of the Central Nervous System
II. Models of EAE in the Mouse
III. Evaluation of the Disease
Chapter 2. Rat Experimental Autoimmune
Encephalomyelitis
I. History and Introduction
Chapter 3. Theiler's Virus-Induced
Demyelinating Disease
I. History and Relevance of the Model
III. Genetics of Susceptibility or Resistance
Chapter 4. Experimental Autoimmune Neuritis
II. Isolation and Composition of Peripheral Nerve Myelin
III. Basic Features of EAN
IV. Immunopathogenesis of EAN—A Model for Therapeutic Studies
Chapter 5. Experimental Autoimmune
Uveoretinitis—Rat and Mouse
Chapter 6. Experimental Autoimmune
Myasthenia Gravis
II. Immunization against Purified Electric Organ AChR
III. Assessment of EAMG and the Safety Factor
IV. Immunization against Purified Mammalian AChR
V. Immunization without Adjuvant
VI. Genetics of EAMG in Rats and Mice
VII. T- and B-Cell Epitopes in EAMG
VIII. Immunization against Denatured AChR Subunits, Recombinant or Synthetic Peptides
XI. Use of EAMG for Therapeutic Studies
XII. Relation to Human Disease
XIV. Lambert-Eaton Myasthenic Syndrome
Chapter 7. The Obese Strain of Chickens with Spontaneous Autoimmune Thyroiditis as a Model for Hashimoto Disease
II. History and Development of the OS
III. Clinical Symptoms and Pathohistology
IV. Immunological Parameters
V. Breeding and Management of OS Chickens
VII. Comparison of SAT and EAT
VIII. Use of the OS for the Development of New
Therapeutic Strategies
Chapter 8. Experimental AutoimmuneThyroiditis in the Mouse and Rat
I. Experimental Autoimmune Thyroiditis in the Mouse
II. Experimental Autoimmune Thyroiditis in the Rat
Chapter 9. The NOD Mouse: A Model
for Autoimmune Insulin-Dependent Diabetes
V. Treatment and Prevention
VI. Notes for the Beginner
VII. What the Model Has Taught Us about Human IDDM
Chapter 10.
The BB Rat Models of IDDM
Chapter 11.
Experimental Myocarditis
II. Production of Virus-Induced Myocarditis
III. Production of Myosin-lnduced Myocarditis
Chapter 12.
Experimental Hepatitis
I. History of Experimental Autoimmune Hepatitis
IV. Induction and Time Course
Chapter 13.
Adjuvant Arthritis
III. Induction of the Disease
IV. Course of the Disease
V. Quantitation of the Disease
VI. Resistance to the Disease
Chapter 14. Murine Models of Spontaneous Systemic Lupus Erythematosus
Chapter 15. Experimental Systemic Lupus Erythematosus: Role of the Idiotypic Network
VI. Resistance to the Disease
VII. Manipulation of the Disease
Chapter 16.
Autoimmune Vasculitis
I. Introduction and History of the Model
V. Lesion and Course of the Disease
Chapter 17. Testicular and Ovarian Autoimmune Diseases
II. Experimental Autoimmune Orchitis
III. Experimental Autoimmune Oophoritis
IV. Autoimmune Oophoritis Following Manipulation of the
Normal Murine Immune System
V. Summary and Conclusions
Chapter 18.
Allogeneic Diseases
I. Chronic Graft-versus-Host Disease
II. Host-versus-Graft Disease
Chapter 19. Assessment of Discomfort in
Laboratory Animals
II. Arguments for Assessing Discomfort
III. Stress and Discomfort
IV. Assessment of Discomfort
V. An Example of Assessing Discomfort in Practice
VI. Possibilities for Diminishing Discomfort